New PCI Capacity Reduced Heart Attack Deaths Only Where Access Was Missing
Opening a PCI-capable hospital within reach of a community did not produce the same result everywhere. In California, the mortality benefit appeared where timely catheterization care had been absent, and it largely disappeared where patients already had access within 30 minutes.
The pattern is blunt. More specialized capacity helped when it closed a real geographic gap, but it added little when the local system was already able to deliver percutaneous coronary intervention quickly.
Researchers at the University of California, San Francisco examined 590,282 heart attack hospitalizations across California from 2011 through 2022 to see what happened after a new PCI-capable facility opened near a community. The analysis compared communities that previously lacked timely PCI access with those that already had it, using a 30-minute drive threshold as the operational marker of access. In communities without prior access, a new facility was linked to a 53% relative increase in admission to a PCI-capable hospital and a 16% increase in patients actually receiving PCI. Those changes tracked with a 20% reduction in 30-day mortality and a 15% reduction in one-year mortality.
In places where PCI was already available within 30 minutes, the numbers moved only slightly. Admission to a PCI-capable hospital increased by 2%, PCI use increased by 3%, and mortality did not change in a statistically meaningful way.
Geography Determined Who Benefited
The study makes a familiar point with fresh force: in emergency cardiovascular care, distance still functions as a biologic and operational barrier. A patient with an evolving myocardial infarction does not benefit from a theoretical service line somewhere in the region; benefit depends on whether the right facility can be reached quickly enough for reperfusion to matter.
Renee Y. Hsia, MD, MSc, a UCSF professor of emergency medicine and senior author of the study, framed the issue plainly. Americans may assume more services automatically mean better care, but location determines whether an added hospital changes outcomes or merely spreads capacity across places that were already served.
The rural data sharpened that point. Of 52,756 heart attack patients from rural California communities included in the analysis, 81% lived in areas without a PCI-capable facility within 30 minutes at the start of the study period. That kind of geographic deficit is not a minor inconvenience. It can determine whether a patient receives rapid revascularization, arrives too late for the myocardium at risk, or is transferred after irreversible injury has already occurred.
Why the Survival Signal Appeared Only in Underserved Areas
The mechanism is straightforward. PCI works best when it can rapidly restore coronary blood flow during acute ischemia. Every additional mile, transfer step, or delay before balloon inflation can enlarge infarct size and raise the risk of malignant arrhythmia, shock, and death. When a new facility appears in a community that previously lacked timely access, it shortens the interval from symptom onset to reperfusion and raises the probability that STEMI and other high-risk acute coronary presentations receive definitive treatment in time.
Where PCI was already nearby, another hospital changed little because the bottleneck was not availability. The region already had a route to reperfusion, so adding another destination increased treatment volume only modestly. In that setting, the limiting factor was less about access and more about redundancy.
The data fit a broader health services principle: a specialized intervention delivers the largest population benefit when it reaches people who were previously excluded from it by geography, transportation, or system design. Adding capacity into an already saturated corridor may still matter for convenience, throughput, or local competition, but it does not automatically translate into lower mortality.
Rural Patients Carried the Heaviest Burden
Rural communities stood out because the access gap was widest there. Hospitals in those areas often face a difficult equation: the equipment, staffing, and 24/7 readiness required for a catheterization lab are expensive, yet local volume may be too low to justify the investment under ordinary market logic. The study places a hard clinical consequence on that financial calculation.
A patient living where the nearest PCI-capable center is 30 miles away faces more than inconvenience. Delays can limit eligibility for PCI, force greater reliance on transfer networks, and increase the odds that clinicians must manage a higher-risk myocardial infarction without immediate access to definitive coronary intervention. In emergency cardiology, those delays are not abstract. They translate into tissue loss and downstream mortality.
Hsia compared the concept to adding a gas station in an already crowded neighborhood versus placing one where drivers previously had to travel far for fuel. The analogy fits because emergency cardiovascular care behaves the same way: the benefit comes from filling a void, not from adding another option where options already exist.
Earlier Capacity Data Pointed in the Same Direction
This study extended earlier work from the same research group. Prior analysis found that the number of PCI procedures in a community rose 7.5% after a new facility opened. The increase was close to 20% in communities that previously lacked timely access, compared with about 8% where PCI was already available.
The new analysis asks the harder question: does more procedure volume mean better survival? Only when the added capacity repaired a geographic gap. Where access was already in place, the extra hospital produced small changes in utilization without a detectable mortality gain.
That distinction should matter to health system leaders deciding where to invest capital. Specialized programs are costly. Cath labs require technology, trained personnel, and continuous readiness, and those fixed costs often push hospitals to think about return on investment before population need. The study suggests that the best place to deploy those resources is not necessarily where margins are strongest, but where patients currently fall outside the reach of timely care.
Practical Implications for Cardiologists and Primary Care Clinicians
For cardiologists, emergency physicians, and primary care clinicians in underserved regions, the findings translate into a familiar bedside reality: patients who live far from PCI centers carry a higher baseline risk after acute coronary events. That raises the importance of prevention, rapid recognition of symptoms, prehospital activation, and transfer pathways that can compress time to reperfusion.
For primary care clinicians, the message also reaches upstream. Aggressive control of hypertension, diabetes, hyperlipidemia, smoking, and other modifiable risk factors matters even more when a community lacks nearby PCI access, because preventing the infarction may be the most reliable way to offset the penalty of distance.
The policy lesson is just as direct. Expanding specialized cardiac services can save lives, but only when expansion is targeted to the communities that are still waiting for access. Where the service already exists, more capacity may improve convenience and throughput. Where it does not, the same investment can change survival.
The study leaves open practical questions about how best to identify which communities should get the next cath lab, how transfer systems can compensate when new facilities are not feasible, and how regional planners should balance volume, cost, and emergency coverage. Those choices will determine whether added cardiac capacity functions as true access or simply as duplication.